Condensed Consolidated Statements of Cash Flows (Unaudited) $ in Thousands, € in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)
Cash flows from operating activities:
Net income	$ 33,327	$ 12,667
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	9,137	6,209
Gain on disposal of property, plant & equipment	(6,206)	(43)
Gain on sale of Molded Fiber business	(15,623)	0
Share-based compensation	2,370	1,771
Interest expense on finance leases	4	2
Deferred income taxes	415	482
Change in fair value of contingent consideration	9,348	0
Changes in operating assets and liabilities:
Receivables, net	(19,841)	(6,028)
Inventories	(20,085)	(3,032)
Prepaid expenses and other current assets	118	(517)
Refundable income taxes	(3,624)	(848)
Other assets	(2,637)	72
Accounts payable	6,334	3,210
Accrued expenses	12,987	417
Deferred revenue	501	(216)
Non-qualified deferred compensation plan and other liabilities	(6,669)	(469)
Net cash provided by operating activities	(144)	13,677
Cash flows from investing activities:
Additions to property, plant, and equipment	(10,816)	(4,277)
Proceeds from sale of Molded Fiber	29,007	0
Proceeds from sale of fixed assets	6,717	51
Net cash provided by (used in) investing activities	4,255	(4,226)
Cash flows from financing activities:
Proceeds from advances on revolving line of credit	44,000	0
Payments on revolving line of credit	(45,000)	0
Principal payments of long-term debt	(3,000)	0
Principal payments on finance lease obligations	(47)	(13)
Proceeds from exercise of stock options	367	162
Payment of statutory withholdings for restricted stock units vested	(1,491)	(740)
Net cash used in financing activities	(5,171)	(591)
Effect of foreign currency exchange rates on cash and cash equivalents	(120)	0
Net (decrease) increase in cash and cash equivalents	(1,180)	8,860
Cash and cash equivalents at beginning of period	11,117	24,234
Cash and cash equivalents at end of period	9,937	33,094
Advant Medical [Member]
Cash flows from investing activities:
Acquisition, net of cash acquired	(20,768)	0
DAS Medical [Member]
Cash flows from investing activities:
Acquisition, net of cash acquired	$ 115	$ 0